A population-based study on variations in the use of adjuvant systemic therapy on postmenopausal patients with early stage breast cancer

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Cancer Research and Clinical Oncology

• Publication date

  2003-04-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00432-003-0417-yPMID 12709795PMCID PMC12161942
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Applied Logistic Regression: Hosmer/Applied Logistic Regression

  2005cited by this paper
• Variations in breast cancer treatment by patient and provider characteristics

  2005cited by this paper
• Logistic Regression: A Self-Learning Text

  2003cited by this paper
• Primary breast cancer therapy in six regions of Germany.

  2002cited by this paper
• Expert Commentary.

  2002influential reference
• Specialization and cancer: words with too many meanings should be handled with care.

  2001cited by this paper
• Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older.

  2001cited by this paper
• Bladder cancer chemotherapy trial generates more questions than it answers.

  2001cited by this paper
• National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

  2001cited by this paper
• What threshold for adjuvant therapy in older breast cancer patients?

  2000cited by this paper
• Patterns of breast carcinoma treatment in older women

  2000cited by this paper
• Impact of breast cancer treatment guidelines on surgeon practice patterns: results of a hospital-based intervention.

  2000cited by this paper
• Management of cancer in the older person: a practical approach.

  2000cited by this paper
• Management of Cancer in the Older Person : A Practical Approach

  2000cited by this paper
• Review of organizational factors related to care offered to women with breast cancer.

  2000cited by this paper
• Clinical practice guidelines.

  1999cited by this paper
• Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women

  1999cited by this paper
• Pathological prognostic factors in breast cancer.

  1999cited by this paper
• Comorbidity and functional status are independent in older cancer patients.

  1998cited by this paper
• Polychemotherapy for early breast cancer: an overview of the randomised trials

  1998cited by this paper
• Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

  1998cited by this paper
• Use of breast-conserving surgery for treatment of stage I and stage II breast cancer.

  1998cited by this paper
• Age-related patterns of care: evidence against ageism in the treatment of early-stage breast cancer.

  1997cited by this paper
• Cancer burden in the aged

  1997cited by this paper
• Variation in management of small invasive breast cancers detected on screening in the former South East Thames region: observational study

  1997cited by this paper
• The impact of age, marital status, and physician‐patient interactions on the care of older women with breast carcinoma

  1997cited by this paper
• Compliance with practice guidelines for node-negative breast cancer.

  1997cited by this paper
• Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials.

  1996cited by this paper
• Practical considerations on the use of the Charlson comorbidity index with administrative data bases.

  1996cited by this paper
• Factors associated with surgical and radiation therapy for early stage breast cancer in older women.

  1996cited by this paper
• The effect of age and comorbidity in the treatment of elderly women with nonmetastatic breast cancer.

  1996cited by this paper
• Influence of clinician workload and patterns of treatment on survival from breast cancer.

  1995cited by this paper
• Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.

  1995cited by this paper
• The Effect of Comorbidity on 3-Year Survival of Women with Primary Breast Cancer

  1994cited by this paper
• Cancer treatment and age: patient perspectives.

  1993cited by this paper
• Breast cancer in Western Australia in 1989. II. Diagnosis and primary management.

  1993cited by this paper
• Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group.

  1992cited by this paper
• Variations in breast cancer management between a teaching and a non-teaching district.

  1992cited by this paper
• Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group.

  1992cited by this paper
• Institute of Medicine Committee on Clinical Practice Guidelines

  1992cited by this paper
• Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group.

  1992cited by this paper
• Does (or should) chronologic age influence the choice of cancer treatment?

  1992cited by this paper
• pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

  1991cited by this paper
• National Institutes of Health Consensus Development Conference Statement: Geriatric Assessment Methods for Clinical Decision‐making

  1988cited by this paper
• Patterns of care related to age of breast cancer patients.

  1987cited by this paper
• Factors influencing options in primary breast cancer treatment.

  1987cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper
• Breast Cancer — Patient Choice of Treatment: Preliminary Communication

  1985cited by this paper
• Histological Grading and Prognosis in Breast Cancer

  1957cited by this paper

• Influence of comorbidity on chemotherapy use for early breast cancer: systematic review and meta-analysis

  2017cites this paper
• Economic impact of 21-gene recurrence score testing on early-stage breast cancer in Ireland

  2015cites this paper
• Is standard breast-conserving therapy (BCT) in elderly breast cancer patients justified? A prospective measurement of acute toxicity according CTC-classification

  2010cites this paper
• Psychosocial Influences on Suboptimal Adjuvant Breast Cancer Treatment Adherence Among African American Women: Implications for Education and Intervention

  2008cites this paper
• Older women with operable breast cancer are less likely to have surgery

  2007cites this paper
• Non-standard management of breast cancer increases with age in the UK: a population based cohort of women ⩾65 years

  2007cites this paper
• Safety of aromatase inhibitors in the adjuvant setting

  2007cites this paper
• The roles of teaching hospitals, insurance status, and race/ethnicity in receipt of adjuvant therapy for regional-stage breast cancer in Florida.

  2006cites this paper
• Economic analysis of targeting chemotherapy using a 21-gene RT-PCR assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer.

  2005cites this paper
• The impact of comorbidity on the survival of postmenopausal women with breast cancer

  2004cites this paper